Karyopharm Therapeutics, Inc. (KPTI)

10.30 +0.63 (+6.51%) USD  |  NASDAQ  |  Feb 23, 14:12
More

Karyopharm Therapeutics Capital Expenditures (Quarterly)

Capital Expenditures (Quarterly) Chart

View Capital Expenditures (Quarterly) for KPTI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Capital Expenditures (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Capex Definition

View Capex Definition
Start Trial

Capital expenditures are a line item from a company's statement of cash flows.

Read full definition.

Capital Expenditures (Quarterly) Range, Past 5 Years

View Capital Expenditures (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Capital Expenditures (Quarterly) Benchmarks

View Capital Expenditures (Quarterly) Benchmarks
Start Trial
Alnylam Pharmaceuticals, Inc. Upgrade
Baxter International, Inc. Upgrade
Bruker Corp. Upgrade
Catalyst Pharmaceuticals, Inc. Upgrade
Agios Pharmaceuticals, Inc. Upgrade